Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4297588

ODEVIXIBAT
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(=O)O)c3ccc(O)cc3)cc2S(=O)(=O)N1

Basic Information

ChEMBL ID CHEMBL4297588
Name ODEVIXIBAT
Phase Approved
Structure Type MOL
InChI Key XULSCZPZVQIMFM-IPZQJPLYSA-N
Therapeutic ✓ Yes

Known Names

A-4250 A4250 AR-H064974 AZD-8294 AZD8294 Odevixibat
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
0
Publications
6
Known Names
6
Indications
1
Mechanisms

Molecular Properties

740.9
MW (Da)
5.88
ALogP
9
HBA
5
HBD
174.4
PSA (Ų)
0.11
QED
2
Ro5 Violations
17
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2021
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral

Flags

First in Class
USAN Stem -ixibat
USAN Year 2019

Extended Properties

Molecular Formula C37H48N4O8S2
MW 740.94
Aromatic Rings 3
Heavy Atoms 51
NP-Likeness -0.59

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Ileal bile acid transporter inhibitor INHIBITOR Ileal sodium/bile acid cotransporter

Indications

Cholestasis, Intrahepatic Alagille Syndrome Biliary Atresia Cholestasis Liver Cirrhosis, Biliary Non-alcoholic Fatty Liver Disease

ATC Classification

A05AX05
odevixibat
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: BILE AND LIVER THERAPY

Activity Summary

IC50 3 meas. best 9.8

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Bile acid receptor
CHEMBL2047
IC50 9.8 9.8 0.2 1
Unchecked
CHEMBL612545
IC50 9.8 9.8 0.2 2

Activity Data Samples

Top measurements by pChEMBL value

Data from ChEMBL 36 via Core Engine